During the past decade, Second Multiprofile Hospital for Active Treatment Sofia conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 11 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Second Multiprofile Hospital for Active Treatment Sofia" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Shire" with 4 trials sponsored, "Celgene" with 2 trials sponsored, "Phathom Pharmaceuticals, Inc." with 2 trials sponsored and "American Regent, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Second Multiprofile Hospital for Active Treatment Sofia" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Second Multiprofile Hospital for Active Treatment Sofia" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Multiple Sclerosis" (2 trials), "Alzheimer's Disease" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Second Multiprofile Hospital for Active Treatment Sofia" in a lesser frequency.

Most popular intervention types in "Second Multiprofile Hospital for Active Treatment Sofia" are "Drug" (15 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ocrelizumab" (4 trials), "Ontamalimab" (3 trials), "Lansoprazole" (2 trials) and "Vonoprazan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Second Multiprofile Hospital for Active Treatment Sofia" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Second Multiprofile Hospital for Active Treatment Sofia". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Second Multiprofile Hospital for Active Treatment Sofia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Second Multiprofile Hospital for Active Treatment Sofia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".